Agilent Technologies, Inc. $A is Summitry LLC’s 9th Largest Position

Summitry LLC lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 8.1% during the first quarter, HoldingsChannel.com reports. The firm owned 673,954 shares of the medical research company’s stock after purchasing an additional 50,441 shares during the quarter. Agilent Technologies makes up 2.7% of Summitry LLC’s portfolio, making the stock its 9th largest position. Summitry LLC’s holdings in Agilent Technologies were worth $76,817,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Segall Bryant & Hamill LLC purchased a new position in Agilent Technologies during the 1st quarter valued at about $9,041,000. Essential Partners LLC lifted its holdings in shares of Agilent Technologies by 35.1% in the first quarter. Essential Partners LLC now owns 2,658 shares of the medical research company’s stock worth $303,000 after buying an additional 690 shares in the last quarter. Groupe la Francaise lifted its holdings in shares of Agilent Technologies by 15.4% in the first quarter. Groupe la Francaise now owns 39,069 shares of the medical research company’s stock worth $4,453,000 after buying an additional 5,217 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Agilent Technologies by 19.2% in the first quarter. Bank of America Corp DE now owns 1,634,555 shares of the medical research company’s stock valued at $186,307,000 after acquiring an additional 262,781 shares during the period. Finally, Edgestream Partners L.P. boosted its position in shares of Agilent Technologies by 983.6% in the first quarter. Edgestream Partners L.P. now owns 25,346 shares of the medical research company’s stock valued at $2,889,000 after acquiring an additional 23,007 shares during the period.

Agilent Technologies Trading Down 0.3%

Shares of A opened at $138.32 on Friday. The firm’s 50 day simple moving average is $132.35 and its 200 day simple moving average is $125.30. The company has a market capitalization of $39.06 billion, a P/E ratio of 27.77, a P/E/G ratio of 2.46 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on A shares. Royal Bank Of Canada started coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. TD Cowen boosted their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Finally, Jefferies Financial Group initiated coverage on Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $159.35.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.